Ryan Savitz
2023
In 2023, Ryan Savitz earned a total compensation of $329.7K as Chief Financial Officer, Chief Business Officer and Treasurer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $194,140 |
|---|---|
| Salary | $135,511 |
| Total | $329,651 |
Savitz received $194.1K in non-equity incentive plan, accounting for 59% of the total pay in 2023.
Savitz also received $135.5K in salary.
Rankings
In 2023, Ryan Savitz's compensation ranked 2,401st out of 2,918 executives tracked by ExecPay. In other words, Savitz earned more than 17.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,401 out of 2,918 | 18th |
Division Manufacturing | 1,346 out of 1,608 | 16th |
Major group Chemicals And Allied Products | 788 out of 901 | 13th |
Industry group Drugs | 768 out of 864 | 11th |
Industry Pharmaceutical Preparations | 550 out of 622 | 12th |
Source: SEC filing on April 11, 2024.
Savitz's colleagues
We found six more compensation records of executives who worked with Ryan Savitz at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics